Medication-assisted Treatment Market: Competitive Analysis and Key Developments

Medication-assisted Treatment Market: Overview Medication-assisted treatment has become a part of treatment modalities that are combined with counseling and behavioral therapies to provide all-inclusive approach to treating substance use disorders. The medication-assisted treatment market has witnessed its use in alcohol and opioid use disorders. Growing traction of evidence-based treatment options among healthcare providers has been Read More

FDA Warns Website Operators Illegally Selling Opioids to Consumers

The U.S. Food and Drug Administration has issued warning letters to 17 website operators for illegally selling unapproved and misbranded opioids online in violation of the Federal Food, Drug, and Cosmetic Act. Misbranded opioids include those offered for sale without a prescription, as well as opioids that lack adequate directions for use. The opioids offered Read More

For Those Who Are Serious About Increasing Access to MAT for Opioid Use Disorder…

By Jeffrey A. Singer The synthetic opioid methadone, developed in Germany in the 1930s for the treatment of severe pain, has been employed for the Medication Assisted Treatment (MAT) of heroin addiction and opioid use disorder since the 1960s. In the US, methadone clinics are tightly regulated by the Drug Enforcement Administration and the Substance Abuse Read More

Preventing opioid misuse and addiction: New thinking and the latest evidence

Drug policy often comprises efforts to reduce the supply of drugs, to provide health and social services to addicted individuals, and to prevent the development of addiction in the first place. The last of these efforts—prevention—is the subject of this paper. The scientific literature on drug policy offers some insights on the relative effectiveness and Read More